British Columbia is implementing a new policy that will require witnesses for those prescribed a safer supply of drugs. This move aims to prevent the diversion of prescribed opioids, which have been a significant concern in the province. The program, launched in March 2020 during the peak of the COVID-19 pandemic, initially provided take-home safer supply to patients. However, recent revelations of pharmacies offering incentives to clients for prescriptions and the diversion of opioids into the hands of organized criminals led to a shift in the program's approach.
The new guidelines, announced by Health Minister Josie Osborne, mandate that all patients receiving prescribed safer supply must have their consumption witnessed by a medical professional or pharmacist. This change is part of a broader effort to ensure that prescribed alternatives reach those who need them and to prevent the illicit drug supply from causing harm. The government emphasizes that this move is crucial for keeping people alive and connected to care and treatment.
Despite the program's positive impact on reducing overdose deaths and improving patient outcomes, as evidenced by a peer-reviewed study, it has faced criticism. Some doctors argue that the witnessed-only model interferes with medical decision-making and may not support individuals in breaking free from their drug dealers. The debate surrounding this policy highlights the complex nature of addressing substance use disorders and the need for balanced approaches that consider both public health and individual autonomy.
